Join
Live feed
·
INSIDERFilingvia Quantisnow
Monte Rosa Therapeutics Inc. logo

Principal Accounting Officer Dunn Edmund sold $6,166 worth of shares (1,610 units at $3.83), decreasing direct ownership by 10% to 13,944 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLUE (Monte Rosa Therapeutics Inc.) and more on Quantisnow.